169 related articles for article (PubMed ID: 15970286)
21. A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania species.
Teixeira MC; de Jesus Santos R; Sampaio RB; Pontes-de-Carvalho L; dos-Santos WL
Parasitol Res; 2002 Nov; 88(11):963-8. PubMed ID: 12375160
[TBL] [Abstract][Full Text] [Related]
22. Leishmania major: in vitro and in vivo anti-leishmanial effect of cantharidin.
Ghaffarifar F
Exp Parasitol; 2010 Oct; 126(2):126-9. PubMed ID: 20435039
[TBL] [Abstract][Full Text] [Related]
23. Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation.
Kram D; Thäle C; Kolodziej H; Kiderlen AF
J Immunol Methods; 2008 Apr; 333(1-2):79-88. PubMed ID: 18313691
[TBL] [Abstract][Full Text] [Related]
24. Moroccan strains of Leishmania major and Leishmania tropica differentially impact on nitric oxide production by macrophages.
Maksouri H; Dang PM; Rodrigues V; Estaquier J; Riyad M; Akarid K
Parasit Vectors; 2017 Oct; 10(1):506. PubMed ID: 29061164
[TBL] [Abstract][Full Text] [Related]
25. Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages.
Nacy CA; Meltzer MS; Leonard EJ; Wyler DJ
J Immunol; 1981 Dec; 127(6):2381-6. PubMed ID: 7299130
[TBL] [Abstract][Full Text] [Related]
26. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
[TBL] [Abstract][Full Text] [Related]
27. Detection of anti-leishmanial effect of the Lucilia sericata larval secretions in vitro and in vivo on Leishmania tropica: first work.
Polat E; Cakan H; Aslan M; Sirekbasan S; Kutlubay Z; Ipek T; Ozbilgin A
Exp Parasitol; 2012 Oct; 132(2):129-34. PubMed ID: 22750454
[TBL] [Abstract][Full Text] [Related]
28. Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species.
Poorrajab F; Ardestani SK; Foroumadi A; Emami S; Kariminia A; Behrouzi-Fardmoghadam M; Shafiee A
Exp Parasitol; 2009 Apr; 121(4):323-30. PubMed ID: 19124020
[TBL] [Abstract][Full Text] [Related]
29. Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity.
Bhattacharjee S; Gupta G; Bhattacharya P; Mukherjee A; Mujumdar SB; Pal A; Majumdar S
J Antimicrob Chemother; 2009 Feb; 63(2):317-24. PubMed ID: 19036753
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Leishmania (Leishmania) amazonensis growth and infectivity by aureobasidin A.
Tanaka AK; Valero VB; Takahashi HK; Straus AH
J Antimicrob Chemother; 2007 Mar; 59(3):487-92. PubMed ID: 17242034
[TBL] [Abstract][Full Text] [Related]
31. Leishmania infantum amastigotes resistant to nitric oxide cytotoxicity: Impact on in vitro parasite developmental cycle and metabolic enzyme activities.
Holzmuller P; Hide M; Sereno D; Lemesre JL
Infect Genet Evol; 2006 May; 6(3):187-97. PubMed ID: 15905133
[TBL] [Abstract][Full Text] [Related]
32. EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica.
El Hajj R; Bou Youness H; Lachaud L; Bastien P; Masquefa C; Bonnet PA; El Hajj H; Khalifeh I
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006854. PubMed ID: 30462645
[TBL] [Abstract][Full Text] [Related]
33. Leishmanicidal activity of Yucatecan medicinal plants on Leishmania species responsible for cutaneous leishmaniasis.
Getti G; Durgadoss P; Domínguez-Carmona D; Martin-Quintal Z; Peraza-Sánchez S; Peña-Rodriguez LM; Humber D
J Parasitol; 2009 Apr; 95(2):456-60. PubMed ID: 18771334
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of anti-leishmanial effects of killed Leishmania vaccine with BCG adjuvant in BALB/c mice infected with Leishmania major MRHO/IR/75/ER.
Nahrevanian H; Jafary SP; Nemati S; Farahmand M; Omidinia E
Folia Parasitol (Praha); 2013 Feb; 60(1):1-6. PubMed ID: 23539946
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
[TBL] [Abstract][Full Text] [Related]
36. Passive transfer of Leishmania lipopolysaccharide confers parasite survival in macrophages.
Handman E; Schnur LF; Spithill TW; Mitchell GF
J Immunol; 1986 Dec; 137(11):3608-13. PubMed ID: 3782793
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of Leishmania tropica protein kinase CK2 activities by platelet-activating factor (PAF).
Dutra PM; Vieira DP; Meyer-Fernandes JR; Silva-Neto MA; Lopes AH
Acta Trop; 2009 Sep; 111(3):247-54. PubMed ID: 19433049
[TBL] [Abstract][Full Text] [Related]
38. Leishmania spp.: mechanisms of toxicity of nitrogen oxidation products.
Mauël J; Ransijn A
Exp Parasitol; 1997 Oct; 87(2):98-111. PubMed ID: 9326885
[TBL] [Abstract][Full Text] [Related]
39. Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.
Miguel DC; Yokoyama-Yasunaka JK; Andreoli WK; Mortara RA; Uliana SR
J Antimicrob Chemother; 2007 Sep; 60(3):526-34. PubMed ID: 17584801
[TBL] [Abstract][Full Text] [Related]
40. Antileishmanial activity and immune modulatory effects of tannins and related compounds on Leishmania parasitised RAW 264.7 cells.
Kolodziej H; Kiderlen AF
Phytochemistry; 2005 Sep; 66(17):2056-71. PubMed ID: 16153409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
